Maher, A., Arif, S., Madhani, M., Abozguia, K., Ahmed, I., Fernandez, B., Feelisch, M., O'Sullivan, A., Christopoulos, A., Sverdlov, A., Ngo, D., Dautov, R., James, Philip, Horowitz, J. and Frenneaux, M. 2013. Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite. British Journal of Pharmacology 169 (3) , pp. 659-670. 10.1111/bph.12152 |
Abstract
BACKGROUND AND PURPOSE: Nitrite (NO2 -) has recently been shown to represent a potential source of NO, in particular under hypoxic conditions. The aim of the current study was to compare the haemodynamic effects of NO2 - in healthy volunteers and patients with stable congestive heart failure (CHF). EXPERIMENTAL APPROACH: The acute haemodynamic effects of brachial artery infusion of NO2 - (0.31 to 7.8 μmol·min-1) was assessed in normal subjects (n = 20) and CHF patients (n = 21). KEY RESULTS: NO2 - infusion was well tolerated in all subjects. Forearm blood flow (FBF) increased markedly in CHF patients at NO2 - infusion rates which induced no changes in normal subjects (anova: F = 5.5; P = 0.02). Unstressed venous volume (UVV) increased even with the lowest NO2 - infusion rate in all subjects (indicating venodilation), with CHF patients being relatively hyporesponsive compared with normal subjects (anova: F = 6.2; P = 0.01). There were no differences in venous blood pH or oxygen concentration between groups or during NO2 - infusion. Venous plasma NO2 - concentrations were lower in CHF patients at baseline, and rose substantially less with NO2 - infusion, without incremental oxidative generation of nitrate, consistent with accelerated clearance in these patients. Plasma protein-bound NO concentrations were lower in CHF patients than normal subjects at baseline. This difference was attenuated during NO 2 - infusion. Prolonged NO2 - exposure in vivo did not induce oxidative stress, nor did it induce tolerance in vitro. CONCLUSIONS AND IMPLICATIONS: The findings of arterial hyper-responsiveness to infused NO2 - in CHF patients, with evidence of accelerated transvascular NO2 - clearance (presumably with concomitant NO release) suggests that NO2 - effects may be accentuated in such patients. These findings provide a stimulus for the clinical exploration of NO2 - as a therapeutic modality in CHF.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > R Medicine (General) R Medicine > RZ Other systems of medicine |
Uncontrolled Keywords: | Aged; Brachial Artery; Cohort Studies; Drug Tolerance; Female; Forearm; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Metabolic Clearance Rate; Middle Aged; Nitric Oxide; Nitroglycerin; Oxidative Stress; Regional Blood Flow; Saphenous Vein; Sodium Nitrite; Vasodilation; Vasodilator Agents; Vasomotor System |
Publisher: | Nature Publishing Group |
ISSN: | 0007-1188 |
Last Modified: | 20 Mar 2016 00:00 |
URI: | https://orca.cardiff.ac.uk/id/eprint/76609 |
Citation Data
Cited 20 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |